“August, the month of the second doses”: the vaccination rate has dropped, more schedules have been completed and a question arises about AstraZeneca

At ten days from the beginning of August, which the Ministry of Health of the Nation classified as “the second doses”, we can see a Lower vaccination rate in Argentina, an increase in the percentage of complete diagrams and a question about people who received serums from AstraZeneca.

During the month of August, the government proposed that two-dose coverage reach 60% of adults over 50. Last Friday Alberto Fernández promised 7 million vaccines they should arrive before STEP. According to the figures consulted TN.com.ar, currently 43.2% of this group have full diets. To achieve this goal, he allowed the combination of Sputnik V with Moderna and AstraZeneca serums.

Indeed, figures from the Public Vaccination Monitor show that during the first days of this month the rate of application of the second doses increased, but the same figures show that inoculation with dose 1 was reduced. Between July 26 and August 1, some 2,404,008 doses, while between the 2nd and 8th of this month this figure decreased to 2,160,303, or 10.13% less (258,601 sera).

At the Ministry of Health of the Nation, they explain that this slight decrease is due to the fact that the placement of the second doses is a priority, which leads to delivering fewer teams to apply the first. Still according to public data, vaccines distributed climbed to 40,647,064 while those applied are 34,993,614.

Of this total, 26,201,942 correspond to dose 1, while 8,791,672 people have already completed their vaccination schedule. The age group of people aged 60 and over has already received 9,848,224 sera. Taking into account the fact that the Government estimated this population at 7,279,394 people, There are still approximately 4,710,564 sera to be placed in this group to immunize it with two applications.

The acceleration of the doses of doses is explained by the application of the 1 514 940 Moderna serums that the government started distributing last week. These are vaccines offered by the United States government and are also used to immunize some 900,000 minors with co-morbidities. The Ministry of Health reports that around 100,000 doses have already been placed in this priority group. The objective is to work with municipalities and provinces to promote vaccination among the youngest.

From the figures he was able to collect TN.com.ar from various health sources, about 2,300,000 people over the age of 60 are waiting for the second component of Russian serum across the country, a good part of which is located in the City and Province of Buenos Aires, which brings together 1.7 million citizens who are in this situation.

Of the total, 1,500,000 Buenos Aires have already passed the 90-day window from the first application, while in town they are 213 thousand neighbors who must complete their plans after receiving a dose of Russian serum.

Vaccination schedules for adults over 60 could be completed quickly if Argentina has a stockpile of AstraZeneca doses, but failure to adhere to this lab is forcing jurisdictions to rethink the use of each vaccine that reaches the country. For example, the City and Province of Buenos Aires will not provide these serums in combination but in a second dose for those who have already received the first.

Just over 200,000 doses of the Oxford-developed vaccine arrived on Monday, and authorities are once again concerned about delivery delays. Of the initial contract of 22.4 million doses, there are still around 12 million to arrive. Although there is no public data, at least 6 million people under the age of 60 received the first dose of AstraZeneca and at some point, they should finish their plan. A percentage of this number is on the verge of reaching the 56 day window between the first and second inoculation.

The need to place second doses is increasing due to the risk that the Delta variant of the coronavirus circulates in a community way in the country. As confirmed by the director of epidemiology and strategic information Analía Rearte, there are 127 confirmed cases of this lineage in the country linked to travelers. The office told the Federal Health Council that “we still do not have predominant transmission.”